Preparation of N-trimethyl chitosan-protein nanoparticles intended for vaccine delivery

Journal of Nanoscience and Nanotechnology

Volumn 10, Issue 8, 2010, Pages 4850-4858

  Li, Xing Yi ^a   Li, Xiang ^b   Kong, Xiang Ye ^a   Shi, Shuai ^a   Guo, Gang ^a   Zhang, Juan ^a   Luo, Feng ^a   Zhao, Xia ^a   Wei, Yu Quan ^a   Qian, Zhi Yong ^a   Yang, Li ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Alginate; Cytotoxicity; In vitro release; N trimethyl chitosan nanoparticle

Indexed keywords

ACIDIC CONDITIONS; ACIDIC SOLUTIONS; ALGINATE MODIFICATION; BURST RELEASE; CELL ACTIVITY; HEK-293; IN-VITRO; IONIC GELATION METHOD; LOADING CAPACITIES; LOADING EFFICIENCY; ORAL DELIVERY; PHOSPHATE BUFFERS; RELEASE TIME; SDS-PAGE; SDS-POLYACRYLAMIDE GEL ELECTROPHORESIS; TRIMETHYL CHITOSAN; VACCINE DELIVERY;

ALGINATE; CHITIN; CHITOSAN; COAGULATION; CYTOTOXICITY; ELECTROPHORESIS; GELATION; LOADING; MOLECULAR WEIGHT;

NANOPARTICLES;

ALGINIC ACID; BOVINE SERUM ALBUMIN; CHITOSAN; GLUCURONIC ACID; HEXURONIC ACID; N TRIMETHYL CHITOSAN CHLORIDE; N-TRIMETHYL CHITOSAN CHLORIDE; NANOPARTICLE; VACCINE;

ANIMAL; ARTICLE; ATOMIC FORCE MICROSCOPY; CATTLE; CELL LINE; CELL STRAIN HEK293; CELL SURVIVAL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECT; HUMAN; MATERIALS TESTING; METHODOLOGY; MOLECULAR WEIGHT; MOUSE; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; PH; POLYACRYLAMIDE GEL ELECTROPHORESIS;

ADMINISTRATION, ORAL; ALGINATES; ANIMALS; CATTLE; CELL LINE; CELL SURVIVAL; CHITOSAN; DRUG DELIVERY SYSTEMS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GLUCURONIC ACID; HEK293 CELLS; HEXURONIC ACIDS; HUMANS; HYDROGEN-ION CONCENTRATION; MATERIALS TESTING; MICE; MICROSCOPY, ATOMIC FORCE; MOLECULAR WEIGHT; NANOPARTICLES; PARTICLE SIZE; SERUM ALBUMIN, BOVINE; VACCINES;

EID: 78649499233     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2010.2211     Document Type: Conference Paper

References (41)

1. K. Kurita, Polym. Degrad. Stabil. 59, 117 (1998).
2. G. Skjak-Braek, T. Anthonsen, and P. Standford, Chitin and Chitosan, Elsevier Applied Science. London (1989).
3. B. Veleirinho and I. Delgadillo, J. Nanosci. Nanotechnol. 9, 3798 (2009).
4. Y. Shirosaki, C. M. Bolelho, M. A. Lopes, and J. D. Santos, J. Nanosci. Nanotechnol. 9, 3714 (2009).
5. Y. S. Lin, E. Renbutsu, M. Morimoto, Y. Okamura, T. Tsuka, H. Saimoto, Y. Okamoto, and S. Minami, J. Nanosci. Nanotechnol. 9, 2558 (2009).
6. X. Y. Li, X. L. Zheng, X. W. Wei, G. Guo, M. L. Gou, C. Y. Gong, X. H. Wang, M. Dai, L. J. Chen, and Y. Q. Wei, J. Nanosci. Nanotechnol. 9, 4586 (2009).
7. M. Thanou, J. C. Verhoef, and H. E. Junginger, Adv. Drug. Deliver. Rev. 52, 117 (2001).
8. O. Fell, P. Buri, and R. Gurny, Drug. Dev. Ind. Pharm. 24, 979 (1998).
9. T. Wang, Z. Feng, N. He, Z. Wang, S. Li, Y. Guo, and L. Xu, J. Nanosci. Nanotechnol. 7, 4571 (2007).
10. T. H. Dung, S. R. Lee, S. D. Han, S. J. Kim, Y. M. Ju, M. S. Kim, and H. Yoo, J. Nanosci. Nanotechnol. 7, 3695 (2007).
11. F. Alyabi, F. Talaie, and R. Dinarvand, J. Nanosci. Nanotechnol. 9, 4593 (2009).
12. Y. Boonsongrit, A. Mitrevej, and B. W. Mueller, Eur. J. Pharm. Biopharm. 62, 267 (2006).
13. F. Chen, Z. R. Zhang, F. Yuan, X. Qin, M. Wang, and Y. Huang, Int. J. Pharm. 349, 226 (2008).
14. Q. Gun, T. Wang, C. Cochrane, and P. McCanon, Colloid. Surface. B 44, 65 (2005).
15. R. Hejazi and M. Amiji, J. Control. Release. 89, 151 (2003).
16. L. Illum, N. F. Farraj, and S. S. Davis, Pharm. Res. 11, 1186 (1994).
17. M. N. V. Ravi Kumar, React Funct. Polym. 46, 1 (2000).
18. K. H. Liu, T. Y. Liu, D. M. Liu, and S. Y. Chen, J. Nanosci. Nanotechnol. 9, 1198 (2009).
19. N. Bhattarai, H. R. Ramay, J. Gunn, F. A. Matsen, and M. Zhang, J. Control. Release. 103, 609 (2005).
20. J. Du and Y. L. Hsieh, Cellulose 14, 543 (2007).
21. V. K. Mourya and N. N. Inamdar, React. Funct. Polym. 68, 1013 (2008).
22. T. Li, X. W. Shi, Y. M. Du, and Y. F. Tang, J. Biomed. Mate. Res. A 83, 383 (2007).
23. J. H. Hamman, M. Slander, and A. F. Kotzé. Int. J. Pharm. 232, 235 (2002).
24. M. M. Thanou, J. C. Verhoef, S. G. Romeijn, J. F. Nagelkerke, F. Merkus, and H. E. Junginger, Int. J. Pharm. 185, 73 (1999).
25. M. Amidi, S. G. Romeijn, J. C. Verhoef, H. E. Junginger, L. Bungener, A. Huckriede, D. J. A. Crommelin, and W. Jiskool, Vaccine 25, 144 (2007).
26. R. W. Tilball and E. D. Williamson, Vaccine 19, 4175 (2001).
27. I. M. van der Lubben, J. C. Verhoef, G. Borchard, and H. E. Junginger, Eur. J. Pharm. Sct. 14, 201 (2001).
28. A. R. Kotzé, H. L. Lueßen, B. J. de Leeuw, B. G. de Boer, J. C. Verhoef, and H. E. Junginger, Pharm. Res. 14, 1197 (1997).
29. X. Y. Li, X. Y. Kong, S. Shi, X. L. Zheng, G. Guo, Y. Q. Wei, and Z. Y. Qian, BMC Biotechnol. 89, 1 (2008).
30. M. P. Desai, V. Labhasetwar, G. L. Amidon, and R. J. Levy, Pharm. Res. 13, 1838 (1996).
31. M. P. Desai, V. Labhaselwar, E. Walter, R. J. Levy, and G. L. Amidon, Pharm. Res. 14, 1568 (1997).
32. Z. Jia, D. shen, and W. Xu, Carbohyd. Res. 333, 1 (2001).
33. A. B. Sieval, M. Thanou, A. F. Kotzé, J. C. Verhoef, J. Brussee, and H. E. Junginger, Carhohyd. Polym. 36, 157 (1998).
34. P. Artursson, T. Lindmark, S. S. Davis, and L. Illum, Pharm. Res. 11, 1358 (1994).
35. A. F. Kotze, M. M. Thanou, H. L. Luessen, A. G. De Boer, J. C. Verhoef, and H. E. Junginger, J. Pharm. Sci. 88, 253 (1999).
36. F. Chen, Z. R. Zhang, and Y. Huang, Int. J. Pharm. 336, 166 (2007).
37. M. Amidi, S. G. Romeijn, G. Borchard, H. E. Junginger, W. E. Hennink, and W. Jiskoot, J. Control. Release. 111, 107 (2006).
38. O. Borges, G. Borchard, J. C. Verhoef, A. de Sousa, and H. E. Junginger, Int. J. Pharm. 299, 155 (2005).
39. Q. Zhang, Z. Shen, and T. Nagai, Int. J. Pharm. 218, 75 (2001).
40. Y. N. Konan, R. Gurny, and E. Allémann, Int. J. Pharm. 233, 239 (2002).
41. W. Abdelwahed, G. Degobert, S. Stainmesse, and H. Fessi, Adv. Drug. Deliver. Rev. 58, 1688 (2006).